Safety and efficacy trial evaluating the use of SR34006 [idraparinux sodium] in the treatment of deep vein thrombosis (DVT).
Latest Information Update: 20 Apr 2011
At a glance
- Drugs Idraparinux sodium (Primary) ; Low molecular weight heparins; Vitamin K antagonists
- Indications Deep vein thrombosis
- Focus Registrational; Therapeutic Use
- Acronyms Van Gogh-DVT
- Sponsors Sanofi
- 15 Sep 2006 Status change
- 05 Nov 2005 New trial record.